Cellular immunotherapy for medulloblastoma
Sign Up to like & getrecommendations! Published in 2022 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noac236
Abstract: Abstract Medulloblastoma (MB) is the most common malignant brain tumor in children, making up ~20% of all primary pediatric brain tumors. Current therapies consist of maximal surgical resection and aggressive radio- and chemotherapy. A third… read more here.
Keywords: immunotherapy; immunotherapy medulloblastoma; cellular immunotherapy; oncology ... See more keywords